webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid

  CAS No.: 1537891-69-2   Cat No.: BADC-00963   Purity: ≥95% 4.5  

4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid is a pyridyl disulfide-containing ADC linker facilitating cleavable conjugation with antibodies, enabling controlled payload release and increased ADC selectivity and cytotoxicity in tumor cells.

4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid

Structure of 1537891-69-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C11H15NO2S2
Molecular Weight
257.37
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Canonical SMILES
CC(C)(CCC(=O)O)SSC1=CC=CC=N1
InChI
InChI=1S/C11H15NO2S2/c1-11(2,7-6-10(13)14)16-15-9-5-3-4-8-12-9/h3-5,8H,6-7H2,1-2H3,(H,13,14)
InChIKey
FCKSMEZVBFTODF-UHFFFAOYSA-N
Density
1.3±0.1 g/cm3
Solubility
10 mm in DMSO
Flash Point
205.5±27.6 °C
Index Of Refraction
1.600
Vapor Pressure
0.0±1.0 mmHg at 25°C
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Boiling Point
416.1±41.0 °C at 760 mmHg
Form
Solid

4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid, often referred to as a synthetic organosulfur compound, has significant applications in the field of medicinal chemistry. One of its key applications is as an enzyme inhibitor. This compound’s structure allows it to interact with specific enzymatic pathways, thereby modulating the activity of certain enzymes. By inhibiting enzymes that are overactive in certain diseases, such as cancer or inflammatory conditions, this compound can help in developing targeted therapies. For instance, its disulfide bridge can be crucial in disrupting the function of metalloproteinases involved in tumor progression. In this way, 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid contributes to advancements in drug design and personalized medicine.

Another vital application of 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid is in the realm of analytical chemistry, particularly in studying redox reactions. Due to its unique dual sulfur bonds, the compound serves as an excellent probe or reagent for monitoring redox states in various chemical systems. Analytical techniques involving this compound can help determine the oxidative or reductive potential of an environment, which is essential in fields like biochemistry and environmental science. Moreover, its pyridine moiety offers additional electronic properties that make it useful for spectroscopy and other analytical methods, thus expanding the toolkit available for detailed chemical analysis.

In material science, 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid finds applications in the development of novel materials. The compound’s ability to form disulfide bonds makes it an interesting candidate for crafting self-healing materials. These materials can repair themselves when damaged, much like biological tissues. By incorporating this compound into polymers, researchers can create materials that regain their original state after cracking or breaking. This self-healing property is highly desirable in areas such as aerospace, construction, and consumer electronics, where material longevity and resilience are critical.

Lastly, 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid plays a role in synthetic organic chemistry as a versatile building block. Its functional groups allow for a wide range of chemical modifications, making it valuable for creating more complex molecules. The compound’s disulfide linkage can be cleaved or reformed, providing a dynamic option for synthetic pathways in creating pharmaceuticals, agrochemicals, and specialized industrial chemicals. This adaptability makes it a staple in many synthetic laboratories, where precision and versatility in chemical reactions are paramount.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: β-D-tetraacetylgalactopyranoside-PEG1-N3 | NHS-PEG(5)-CO-OBzl | Propargyl-PEG1-SS-PEG1-PFP ester | 4-Formyl-N-(2-(4-Isopropylphenoxy)ethyl)benzamide | 4-Formyl-N-(2-Phenoxyethyl)benzamide | 2,5-dioxopyrrolidin-1-yl 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate | Fmoc-D-Trp(Boc)-OH | Satralizumab Linker | 4-Formyl-N-(2-(2-Methoxyphenoxy)ethyl)benzamide | CL2A-SN 38 | 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid
Send Inquiry
Verification code
Inquiry Basket